Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42901

CCDC120 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

CCDC120 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of human colorectal adenocarcinoma HT29 cells with targeted disruption of the CCDC120 gene. CCDC120 encodes a centriolar subdistal appendage protein essential for primary cilia formation and regulates Hedgehog and Wnt signaling by interacting with factors such as SMO, GLI1, PTCH1, ??-catenin, and TCF7L2. Loss of CCDC120 impairs ciliogenesis, leading to attenuated signaling output. This model is invaluable for investigating primary cilia function in colorectal cancer, cilia-dependent signaling pathways, and the roles of centriolar proteins. Key applications include immunofluorescence for cilia markers, RT-qPCR for pathway target genes, and functional assays like proliferation and wound healing. Contact Ascent Research for details.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    CCDC120

    Gene Identifier

    NCBI Gene ID 90060

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CCDC120 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population generated from the human colorectal adenocarcinoma HT29 cell line, providing a genetically heterogeneous pool of cells with disrupted CCDC120 gene function through CRISPR/Cas9-mediated gene editing. This polyclonal format captures a range of loss-of-function events, offering a robust tool to study CCDC120 biology without the selection bias of a single clone.

HT29 cells are a widely used human colorectal adenocarcinoma epithelial cell line that produces mucin, representing a model of intestinal epithelium and colorectal cancer. These cells exhibit differentiated characteristics and are extensively employed to investigate signal transduction, cell adhesion, proliferation, and tumorigenesis mechanisms. Their capacity to form primary cilia makes them particularly relevant for studying ciliary protein functions in cancer.

CCDC120 encodes a centriolar protein essential for primary cilium formation, localizing to subdistal appendages of the mother centriole. It directly interacts with ODF2, CEP170, CEP89, and ninein to coordinate ciliogenesis. Loss of CCDC120 disrupts primary cilia, thereby impairing Hedgehog and Wnt signaling pathways. Downstream effects include reduced activation of GLI transcription factors and ??-catenin/TCF-dependent transcription, as well as altered AKT signaling. Key pathway components affected include SMO, GLI1, PTCH1, ??-catenin, and TCF7L2, with upstream regulation by RFX transcription factors and Foxj1.

Within HT29 colorectal cancer cells, CCDC120 knockout impairs ciliogenesis and associated signaling, providing a unique system to examine the interplay between primary cilia and colorectal tumor biology. Defective Hedgehog and Wnt signaling can influence cell proliferation, differentiation, and migration, mirroring aspects of colorectal cancer progression and ciliopathies. This model enables detailed dissection of how ciliary proteins modulate oncogenic pathways and maintain the transformed phenotype.

This knockout cell pool is ideally suited for a broad range of functional studies. Researchers can employ immunofluorescence microscopy with antibodies against acetylated tubulin or ARL13B to visualize cilia, complemented by western blotting for ciliary markers such as IFT88. Transcriptional analyses via RT-qPCR for Hedgehog target genes like GLI1 and PTCH1 can assess pathway activity. Functional assays including wound healing, cell proliferation, and colony formation enable interrogation of oncogenic properties. These tools support mechanistic studies of ciliary proteins in colorectal cancer biology. For further technical information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)